Neurovascular Stent

Neurovascular Stent Market Outlook

The global Neurovascular Stent Market is projected to reach approximately USD 3.5 billion by 2035, growing at a significant compound annual growth rate (CAGR) of around 7.5% from 2025 to 2035. This growth can be attributed to the increasing prevalence of neurovascular diseases such as intracranial aneurysms and acute ischemic strokes, contributing to higher demand for effective treatment options. Additionally, advancements in stent technology, including the development of drug-eluting stents and flow diverters, are enhancing the effectiveness of neurovascular interventions and are likely to drive market growth. Furthermore, the rising elderly population worldwide is expected to increase the incidence of cerebrovascular diseases, thus propelling the demand for neurovascular stents. The growing awareness among healthcare professionals regarding advanced minimally invasive procedures is also expected to positively influence market growth.

Growth Factor of the Market

Several key factors are driving the growth of the neurovascular stent market. Firstly, the rising incidence of cerebrovascular diseases due to an aging population is a critical factor. The World Health Organization (WHO) estimates that the global population aged 60 years and older will reach 2 billion by 2050, leading to higher rates of strokes and related conditions. Secondly, advancements in medical technology, particularly in stent design and materials used, are enhancing the functionality and safety of these devices. Innovations such as bioresorbable stents and drug-eluting options are expanding treatment capabilities and improving patient outcomes. Additionally, increased healthcare spending in both developed and developing regions is facilitating access to advanced medical treatments. The growing number of clinical studies and trials focused on neurovascular interventions is also contributing to a better understanding of these conditions, further driving demand. Finally, the shift towards outpatient treatments and minimally invasive procedures is leading to a surge in the use of neurovascular stents in various clinical settings.

Key Highlights of the Market

• Growing prevalence of neurovascular diseases drives demand for effective treatment options.
• Technological advancements in stent design enhance safety and effectiveness.
• Increased healthcare expenditure supports wider access to neurovascular treatments.
• Shift towards minimally invasive procedures boosts the adoption of stent technologies.
• Rising awareness among healthcare providers regarding advanced treatment options.

By Product Type

Self-Expanding Stents:

Self-expanding stents are designed to automatically expand upon deployment in the intravascular environment. This type of stent is particularly effective in treating conditions such as intracranial aneurysms and stenosis. The unique properties of materials like nitinol, which changes shape with temperature, allow these stents to provide optimal support and maintain vessel patency effectively. Their ability to conform to the vessel walls reduces the risk of complications, making them a preferred choice among neurosurgeons. Moreover, the increasing adoption of self-expanding stents in clinical practice is anticipated to boost their market share significantly over the forecast period, owing to their effectiveness in complex scenarios where precise placement is critical.

Balloon-Expandable Stents:

Balloon-expandable stents are deployed using a balloon catheter that expands the stent to the desired diameter within the vessel. These stents are particularly useful in scenarios where high radial strength is required to maintain vessel lumen. They are extensively used in the treatment of intracranial stenosis and other vascular abnormalities. The balloon-expandable technology offers a reliable option for physicians to achieve optimal vessel diameter, which can be crucial in preventing future occlusions. As the understanding of vascular diseases evolves, the use of balloon-expandable stents is expected to grow, driven by ongoing advancements in balloon materials and design.

Stent-Assisted Coiling:

Stent-assisted coiling is a therapeutic approach that combines the use of stents with coils to treat intracranial aneurysms. This method enhances the stability of coils placed within an aneurysm sac, significantly reducing the risk of coil migration and improving occlusion rates. The increasing preference for this technique among interventional neuroradiologists is expected to augment the growth of the stent-assisted coiling segment in the neurovascular stent market. Furthermore, ongoing research and clinical trials are likely to establish the long-term efficacy of this combined approach, further solidifying its place in treatment protocols.

Flow Diverters:

Flow diverters are specialized stents designed to redirect blood flow away from an aneurysm, promoting healing of the vessel wall and reducing the risk of rupture. These devices are particularly effective for challenging cases of large or wide-necked aneurysms, where traditional techniques may not yield favorable outcomes. The increasing incidence of complex aneurysms is driving demand for flow diverters, making them a critical innovation in the neurovascular stent landscape. As clinical experience with flow diverters increases, they are expected to account for a significant share of the neurovascular stent market, further supported by ongoing advancements in their design and materials.

Drug-Eluting Stents:

Drug-eluting stents are coated with medications that are gradually released to prevent neointimal hyperplasia, a common cause of restenosis. This innovative technology is rapidly gaining traction due to its ability to improve long-term outcomes for patients undergoing neurovascular interventions. As the understanding of drug delivery mechanisms within the vascular system continues to evolve, drug-eluting stents are anticipated to see an increase in adoption rates. The development of new drug formulations and improved stent materials will further enhance the efficacy and safety of this product category, fostering growth in the neurovascular stent market.

By Application

Intracranial Aneurysm:

The treatment of intracranial aneurysms is a significant application area for neurovascular stents, as these stents provide essential support and facilitate intervention techniques such as coiling and flow diversion. The rising prevalence of intracranial aneurysms, coupled with advancements in imaging and intervention technologies, has led to a growing patient population requiring these treatments. Effective management of intracranial aneurysms is paramount, as the risk of rupture can lead to severe complications, including hemorrhagic stroke. As awareness of the implications of untreated aneurysms increases, the demand for neurovascular stents in this segment is expected to rise considerably.

Intracranial Stenosis:

Intracranial stenosis, characterized by the narrowing of blood vessels in the brain, is another critical application for neurovascular stents. These stents are essential in restoring blood flow and preventing ischemic events, which can compromise brain function. The growing incidence of risk factors such as hypertension, diabetes, and hyperlipidemia is contributing to the rising cases of stenosis. With ongoing research into the optimal management of intracranial stenosis, the neurovascular stent market is expected to see increased utilization of stents specifically designed for this condition, leading to improved patient outcomes and quality of life.

Acute Ischemic Stroke:

In the case of acute ischemic stroke, timely intervention is vital to restore blood flow to the affected regions of the brain. Neurovascular stents are increasingly being employed in endovascular procedures to quickly open blocked arteries and minimize brain damage. The growing recognition of the need for rapid treatment options is propelling the market for neurovascular stents in this application area. As technologies evolve and more clinical evidence supports the efficacy of stenting in acute ischemic stroke management, the adoption of these devices is expected to expand significantly in the coming years.

Extracranial Disease:

Extracranial diseases, which affect blood vessels outside the brain, can also necessitate the use of neurovascular stents for effective treatment. These conditions often have repercussions on cerebral perfusion and can lead to severe neurological deficits if left untreated. The stenting procedures designed for extracranial applications are gaining traction as the understanding of their role in comprehensive vascular health improves. As the overall approach to vascular disease management continues to evolve, the incorporation of neurovascular stents in treating extracranial diseases is anticipated to contribute positively to market growth.

Others:

Other applications of neurovascular stents include various vascular anomalies and conditions that may not fall under the primary categories of aneurysms or stenosis. This segment includes the treatment of arteriovenous malformations (AVMs) and other unique vascular challenges. The diversity within this application area presents opportunities for innovation and the adaptation of existing technologies to meet specific clinical needs. As advancements in interventional neuroradiology continue to evolve, the demand for specialized stents catering to these unique applications is expected to grow, further expanding the overall neurovascular stent market.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for neurovascular stents, owing to their advanced facilities and skilled personnel capable of performing complex interventional procedures. The presence of interventional neuroradiology departments in hospitals enables the immediate utilization of stents in emergency settings, particularly for acute conditions such as ischemic strokes and aneurysms. With hospitals often having established relationships with various medical device manufacturers, the procurement of neurovascular stents is streamlined, ensuring timely access for patients. As healthcare systems continue to emphasize rapid response and quality care, the hospital distribution channel is expected to maintain a dominant position in the market.

Specialty Clinics:

Specialty clinics focusing on neurology and interventional radiology have become increasingly relevant in the neurovascular stent market. These clinics provide targeted treatments in a more personalized setting, often leading to improved patient experiences and outcomes. The rise of outpatient procedures and advancements in minimally invasive techniques have made specialty clinics a viable option for patients. Furthermore, as patients seek alternatives to traditional hospital stays, the demand for procedures in specialty clinics is expected to rise, driving the growth of neurovascular stents available through this channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) offer a more efficient and cost-effective option for neurovascular procedures, catering to patients who can undergo certain treatments without extensive hospitalization. These centers are equipped to handle various interventional procedures, including those involving neurovascular stents. The convenience and lower costs associated with ASCs are appealing to both patients and healthcare providers. As more procedures move toward outpatient settings, including those addressing neurovascular conditions, the distribution of stents through ambulatory surgical centers is anticipated to grow significantly, contributing to the broader market expansion.

Online Stores:

The rise of e-commerce has also influenced the distribution of neurovascular stents, particularly with an increasing focus on providing healthcare professionals with easy access to medical devices. Online stores enable hospitals, clinics, and surgical centers to procure neurovascular stents conveniently and efficiently. This distribution channel benefits from rapid delivery options, enhancing patient care by ensuring that necessary devices are available when needed. As technology continues to reshape the landscape of medical device procurement, online stores are expected to gain traction in the neurovascular stent market, allowing for a more streamlined purchasing process.

By Material

Nitinol:

Nitinol, an alloy of nickel and titanium, is increasingly favored in the manufacture of neurovascular stents due to its unique properties, including superelasticity and shape memory. These characteristics allow nitinol stents to provide excellent support while maintaining flexibility, which is critical in navigating the complex vascular environment. The combination of strength and adaptability makes nitinol stents particularly suitable for challenging anatomical configurations, such as those encountered in the treatment of intracranial aneurysms. As the understanding of nitinol's advantages continues to grow, its share in the neurovascular stent market is expected to increase significantly.

Cobalt-Chromium:

Cobalt-chromium alloys are well-regarded for their high strength and corrosion resistance, making them ideal for neurovascular stents that require durability and reliability. The inherent mechanical properties of cobalt-chromium allow for the creation of thinner struts without compromising strength, which is essential for improving blood flow and minimizing restenosis rates. Additionally, the biocompatibility of cobalt-chromium stents enhances patient safety, reducing the risk of adverse reactions. As manufacturers continue to innovate and improve cobalt-chromium technologies, this segment is poised for growth, driven by its established performance in the neurovascular arena.

Platinum-Chromium:

Platinum-chromium stents are recognized for their excellent visibility under fluoroscopy and superior mechanical properties, making them a valuable addition to neurovascular interventions. The enhanced visibility facilitates precise placement during complex procedures, which is crucial for optimal outcomes. Furthermore, platinum-chromium alloys offer a combination of strength and flexibility, enabling the development of advanced stent designs that cater to a variety of clinical needs. As the demand for visibility and performance in neurovascular procedures grows, platinum-chromium stents are expected to gain traction in the market.

Stainless Steel:

Stainless steel has been a traditional material used in the manufacturing of neurovascular stents due to its favorable mechanical properties and biocompatibility. While newer materials have emerged, stainless steel remains relevant in specific applications where cost-effectiveness and reliability are paramount. The ability to fabricate stents with varying strut designs enables customization for specific treatments, allowing for clinical versatility. As the market evolves, stainless steel stents will continue to be an essential segment, particularly in cost-sensitive environments where advanced materials may not be feasible.

Others:

The category of 'Others' encompasses various emerging materials and innovative composites being explored for neurovascular stent applications. Research into bioresorbable stents, which gradually dissolve over time, offers potential for reducing long-term complications associated with permanent implants. Additionally, advancements in coatings and surface treatments aimed at enhancing biocompatibility and reducing thrombogenicity are contributing to the development of novel materials. As material science continues to progress, this segment is expected to experience growth, reflecting the ongoing quest for improved patient outcomes and safety in neurovascular treatments.

By Region

The neurovascular stent market experiences significant regional variations in growth and demand. In North America, particularly in the United States, the market dominates due to advanced healthcare infrastructure, widespread use of neurovascular interventions, and a high prevalence of cerebrovascular diseases. The region is expected to maintain its leading position, with a projected CAGR of approximately 8% from 2025 to 2035, driven by continuous advancements in medical technology and increasing healthcare spending. The presence of major players and ongoing research initiatives also contribute to the robust growth of the neurovascular stent market in North America.

Europe represents a significant portion of the global neurovascular stent market, driven by increasing awareness and education about cerebrovascular diseases among healthcare providers. Countries like Germany, France, and the United Kingdom are at the forefront of adopting innovative medical technologies. The European market is expected to grow steadily, supported by favorable reimbursement scenarios and collaborations between medical device manufacturers and healthcare systems. In Asia Pacific, burgeoning populations and a rising incidence of neurovascular diseases are predicted to drive substantial growth, making it an emerging market with significant potential.

Opportunities

The neurovascular stent market presents numerous opportunities for growth and innovation, particularly with the increasing demand for minimally invasive procedures. As healthcare shifts towards outpatient care and the need for effective treatments rises, there is a growing opportunity for manufacturers to develop advanced stent technologies that cater to these trends. The integration of digital health solutions, such as telemedicine and remote patient monitoring, is likely to enhance the overall treatment experience and improve patient outcomes. Additionally, rising investments in research and development by leading companies are expected to lead to groundbreaking innovations in neurovascular stents, expanding the potential applications and effectiveness of these devices.

Furthermore, the growing focus on preventive healthcare and early intervention presents an opportunity for market players to engage in educational initiatives and awareness campaigns. By promoting the importance of early diagnosis and treatment of neurovascular conditions, companies can help drive demand for neurovascular stents. The expansion of healthcare infrastructure in emerging markets offers another avenue for growth, as increasing access to medical care is likely to result in heightened demand for neurovascular interventions. Strategic partnerships and collaborations between manufacturers, healthcare providers, and research institutions can also foster innovation and enable companies to capitalize on emerging trends effectively.

Threats

Despite the promising outlook for the neurovascular stent market, several threats could hinder its growth. One of the primary challenges is the increasing competition from alternative therapies and treatment modalities that may provide comparable or superior outcomes. As the field of neurology and interventional radiology evolves, newer techniques may emerge, potentially replacing traditional stenting methods. Additionally, stringent regulatory requirements and lengthy approval processes for new devices can impede innovation and market entry for new players, limiting competition and slowing the pace of technological advancements.

Moreover, the rising costs associated with neurovascular interventions can be a deterrent for healthcare systems, especially in regions with limited resources. Economic fluctuations and changing reimbursement policies may also affect the affordability and accessibility of neurovascular stents. The market is also sensitive to shifts in healthcare policies and regulations, which can influence product availability and pricing strategies. Companies operating in this space need to stay agile and adapt to these changes to maintain their competitive edge while continuing to prioritize patient access to effective treatments.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• MicroVention, Inc.
• Johnson & Johnson (Cerenovus)
• Penumbra, Inc.
• BD (Becton, Dickinson and Company)
• B. Braun Melsungen AG
• Cook Medical, LLC
• Asahi Intecc Co., Ltd.
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• InspireMD, Inc.

The competitive landscape of the neurovascular stent market is characterized by the presence of several key players, each vying for market share through innovation and strategic partnerships. Companies such as Medtronic, Boston Scientific, and Abbott are at the forefront, continually advancing their product offerings and acquiring smaller firms to enhance their technological capabilities. These market leaders invest heavily in research and development to introduce new and improved neurovascular stents that cater to evolving patient needs. Their extensive distribution networks and established relationships with healthcare providers further solidify their positions in the market.

Moreover, emerging companies like MicroVention and InspireMD are making significant strides by focusing on niche applications and innovative solutions. These companies often prioritize research-driven approaches, leading to the development of specialized stents that address unique patient requirements. Collaboration between industry players and academic institutions is fostering a spirit of innovation, enabling the rapid translation of research findings into commercially viable products. The competitive dynamics within the neurovascular stent market are expected to intensify as companies strive to differentiate themselves through technological advancements and superior patient outcomes.

In summary, the neurovascular stent market is poised for substantial growth, driven by increasing demand for minimally invasive procedures and advancements in stent technology. Key players such as Stryker and Terumo are focusing on expanding their product portfolios and geographic reach, while also ensuring compliance with regulatory standards. The competitive landscape remains dynamic, with ongoing innovations and collaborations shaping the future of neurovascular interventions. As the market evolves, companies that emphasize patient-centered approaches and invest in research will likely emerge as leaders in this burgeoning industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Penumbra, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 InspireMD, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical, LLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 MicroVention, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Stryker Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B. Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Asahi Intecc Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Merit Medical Systems, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson (Cerenovus)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Neurovascular Stent Market, By Material
    • 6.1.1 Nitinol
    • 6.1.2 Cobalt-Chromium
    • 6.1.3 Platinum-Chromium
    • 6.1.4 Stainless Steel
    • 6.1.5 Others
  • 6.2 Neurovascular Stent Market, By Application
    • 6.2.1 Intracranial Aneurysm
    • 6.2.2 Intracranial Stenosis
    • 6.2.3 Acute Ischemic Stroke
    • 6.2.4 Extracranial Disease
    • 6.2.5 Others
  • 6.3 Neurovascular Stent Market, By Product Type
    • 6.3.1 Self-Expanding Stents
    • 6.3.2 Balloon-Expandable Stents
    • 6.3.3 Stent-Assisted Coiling
    • 6.3.4 Flow Diverters
    • 6.3.5 Drug-Eluting Stents
  • 6.4 Neurovascular Stent Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Neurovascular Stent Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Neurovascular Stent market is categorized based on

By Product Type

• Self-Expanding Stents
• Balloon-Expandable Stents
• Stent-Assisted Coiling
• Flow Diverters
• Drug-Eluting Stents

By Application

• Intracranial Aneurysm
• Intracranial Stenosis
• Acute Ischemic Stroke
• Extracranial Disease
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Stores

By Material

• Nitinol
• Cobalt-Chromium
• Platinum-Chromium
• Stainless Steel
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Stryker Corporation
• Terumo Corporation
• MicroVention, Inc.
• Johnson & Johnson (Cerenovus)
• Penumbra, Inc.
• BD (Becton, Dickinson and Company)
• B. Braun Melsungen AG
• Cook Medical, LLC
• Asahi Intecc Co., Ltd.
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• InspireMD, Inc.